Implementing Components of the Primary Health Care Pre-eclampsia/Eclampsia Model in Bangladesh: A Cost Analysis
The maternal mortality ratio in Bangladesh, as estimated by the 2016 Bangladesh Maternal Mortality and Health Care Survey, is 172 per 100,000 live births [1] . Pre-eclampsia/Eclampsia (PE/E) is the second leading cause of maternal mortality in Bangladesh, accounting for 24% of maternal deaths [2] . PE is identified by high blood pressure and protein in urine within pregnant women after 20 weeks' gestation. Women with PE are at increased risk for organ damage/failure, pre-term birth, loss of pregnancy, and stroke. PE can progress to eclampsia, which is characterized by seizures, and may be associated with kidney and liver damage, as well as maternal death. Infant risks include pre-term birth, low birth weight, stillbirth and death, among others [2] . Infants born pre-term due to PE are at higher risk of long term health issues. The risks of PE/E can be mitigated with regular screening during antenatal care (ANC) as well as the postnatal period. Once detected, regular monitoring of PE can lessen progression to severe PE/E, and severe PE/E can be managed through administration of magnesium sulfate (MgSO 4 ) and antihypertensive drugs [2] . 
COST ANALYSIS METHODOLOGY
The Ending Eclampsia Project in Bangladesh collected retrospective cost data between March and May of 2019. A cost ingredient approach first identified each element (input) required to implement activities for components 1 and 2 of the PHC PE/E Model and then grouped them into cost categories: a) personnel, b) supplies, c) infrastructure (here defined as office costs and any space used for trainings and monitoring visits), d) travel, and e) miscellaneous. For the purposes of the cost analysis, orientation sessions were considered a separate activity because they were conducted jointly for both Components 1 and 2. The economic cost of each activity was calculated regardless of whether the project directly paid for the goods or services. For example, to account for the opportunity cost to providers who participated in a training, their daily wage was calculated although 2 they were not compensated by the project. Estimates for training venues under infrastructure and opportunity costs were also calculated for rooms donated in-kind by MoHFW for some trainings and meeting spaces used for monitoring visits at health facilities. Direct activity costs and project management were also captured. 
COMPONENT 2: INTRODUCING ANTIHYPERTENSIVE DRUGS AT PHC
The Ending Eclampsia project introduced task sharing for provision of the antihypertensive drug oral alpha methyldopa at 31 PHC facilities in two Upazilas. Component 2 included: 1) training providers to identify and classify hypertension in pregnant women, administer antihypertensive drugs, and counsel their clients on signs of PE/E, and 2) routine monitoring and support to PHC providers. Table 2 lists the total costs for implementing the antihypertensive component, USD 40,066 (BDT 3,349,531), with an average cost per provider of USD 817 (BDT 68,358). Of the USD 28,061 in personnel costs, USD 1,727 (6%) were donated or in-kind, and USD 123 of USD 13,529 (a little less than 1%) in infrastructure costs were in-kind from the MoHFW. Figure 3 shows the cost per provider. A total of 49 providers from 31 facilities participated in a one-day training. Among the 49 providers, 31 were FWVs and nurse-midwives who also participated in a one-day refresher training. These trainings were conducted by three trainers and four local program managers. The cost per provider was USD 301 (BDT 25,988). The 31 facilities that participated in the antihypertensive component also received monitoring support. Lessons from implementation of the PE/E PHC Model in Bangladesh could lead to cost savings in future interventions. For example, two providers at each PHC facility were trained in PE/E management, but since typically only one provider is responsible for managing maternal health cases at the PHC level, it may only be necessary to train one provider per facility.
The project directly paid for approximately USD 161,185 (BDT 134,571) or 85% of the personnel costs captured, but it was important to capture the true costs of participants' contributions to the project. Health care providers were taken away from their health facilities and MoHFW staff were unable to partake in other health interventions. This analysis, therefore, captured their opportunity costs, which accounted for approximately 15% of personnel costs. The real opportunity costs to providers, however, vary greatly depending upon responsibility and years of experience. An estimated average was used for this analysis, but in reality this cost calculation varies for each provider.
We also considered estimates for space contributed by MoHFW, because those rooms were unavailable for use by others during Ending Eclampsia activities.
Implementation of the PHC-PE/E Model was generally phased, starting with Component 1 and followed by Component 2. Only the orientation sessions for stakeholders and beneficiaries were jointly implemented. Additional costs could be saved by implementing these two component models concurrently and combining certain activities. For example, if trainings on use of antihypertensive drugs were incorporated into the core component initially, implementation costs would be shared and likely reduced.
To replicate this intervention, infrastructure and travel costs will vary, depending if an implementing organization or agency had already purchased large equipment and could share costs (e.g. vehicles and projectors) among other activities or would need to rent goods and services. Average rental costs were used for this analysis for a broader cost synopsis, although the cost to the project may have been lower.
Exploring ways to integrate the two components of the Ending Eclampsia Model within existing training systems should be explored to further reduce costs. This implementation cost analysis serves as a starting point for those considering implementation of different PHC PE/E Model components.
